Kala Pharmaceuticals

Developer of ophthalmic treatments based on its mucosal penetrating product platform

placeWaltham, Massachusetts, United States calendar_todayFounded 2009 groups34 employees language kalarx.com

Registered entities

Social engagement

Social engagement: 22.9K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

19 investors on record; lead investors include Ysios Capital, Third Rock Ventures, Polaris Partners, Lux Capital.

Investor typeCountShare
Venture capital842%
Private equity316%
Bank & private debt15%
Other / undisclosed737%

Recent activity

14 May 2026
Event
Fierce JPMweek 2026
3 Sep 2025
Event
H.C. Wainwright 27th Annual Global Investment Conference
2 Sep 2025
Leadership hire
President, Chief Executive Officer and Director
Coming soon